These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 24953167)
1. Postpartum changes in methadone maintenance dose. Pace CA; Kaminetzky LB; Winter M; Cheng DM; Saia K; Samet JH; Walley AY J Subst Abuse Treat; 2014 Sep; 47(3):229-32. PubMed ID: 24953167 [TBL] [Abstract][Full Text] [Related]
2. Methadone dosing and prescribed medication use in a prospective cohort of opioid-dependent pregnant women. Cleary BJ; Reynolds K; Eogan M; O'Connell MP; Fahey T; Gallagher PJ; Clarke T; White MJ; McDermott C; O'Sullivan A; Carmody D; Gleeson J; Murphy DJ Addiction; 2013 Apr; 108(4):762-70. PubMed ID: 23216809 [TBL] [Abstract][Full Text] [Related]
3. Characteristics and quality of life of opioid-dependent pregnant women in Austria. Metz VE; Comer SD; Wuerzl J; Pribasnig A; Fischer G Arch Womens Ment Health; 2014 Dec; 17(6):529-39. PubMed ID: 25023716 [TBL] [Abstract][Full Text] [Related]
4. Benzodiazepine withdrawal in pregnant women with opioid use disorders: An observational study of current clinical practices at a tertiary obstetrical hospital. Gopalan P; Moses-Kolko E; Valpey R; Shenai N; Smith E Gen Hosp Psychiatry; 2019; 57():29-33. PubMed ID: 30669023 [TBL] [Abstract][Full Text] [Related]
5. Association of methadone dose with substance use and treatment retention in pregnant and postpartum women with opioid use disorder. Wilder CM; Hosta D; Winhusen T J Subst Abuse Treat; 2017 Sep; 80():33-36. PubMed ID: 28755770 [TBL] [Abstract][Full Text] [Related]
6. Corrected QT Interval and Methadone Dose and Concentrations in Pregnant and Postpartum Women. Bogen DL; Hanusa BH; Perel JM; Sherman F; Mendelson MA; Wisner KL J Clin Psychiatry; 2017; 78(8):e1013-e1019. PubMed ID: 28994902 [TBL] [Abstract][Full Text] [Related]
7. Higher maternal doses of methadone does not increase neonatal abstinence syndrome. Pizarro D; Habli M; Grier M; Bombrys A; Sibai B; Livingston J J Subst Abuse Treat; 2011 Apr; 40(3):295-8. PubMed ID: 21255960 [TBL] [Abstract][Full Text] [Related]
8. Medication assisted treatment discontinuation in pregnant and postpartum women with opioid use disorder. Wilder C; Lewis D; Winhusen T Drug Alcohol Depend; 2015 Apr; 149():225-31. PubMed ID: 25735465 [TBL] [Abstract][Full Text] [Related]
9. Pharmacologic evidence to support clinical decision making for peripartum methadone treatment. Bogen DL; Perel JM; Helsel JC; Hanusa BH; Romkes M; Nukui T; Friedman CR; Wisner KL Psychopharmacology (Berl); 2013 Jan; 225(2):441-51. PubMed ID: 22926004 [TBL] [Abstract][Full Text] [Related]
10. Impact of blended treatment literacy and psychoeducation on methadone maintenance treatment outcomes in Yunnan, China. Zhang B; Cai T; Yan Z; Mburu G; Wang B; Yang L Harm Reduct J; 2016 Feb; 13():8. PubMed ID: 26915361 [TBL] [Abstract][Full Text] [Related]
11. Transitioning from methadone to buprenorphine maintenance in management of opioid use disorder during pregnancy. Johnson S; Martin PR Am J Drug Alcohol Abuse; 2018; 44(3):310-316. PubMed ID: 28829626 [TBL] [Abstract][Full Text] [Related]
12. Duration of methadone maintenance treatment during pregnancy and pregnancy outcome parameters in women with opiate addiction. Peles E; Schreiber S; Bloch M; Dollberg S; Adelson M J Addict Med; 2012 Mar; 6(1):18-23. PubMed ID: 21817914 [TBL] [Abstract][Full Text] [Related]
13. Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study. Nosyk B; Sun H; Evans E; Marsh DC; Anglin MD; Hser YI; Anis AH Addiction; 2012 Sep; 107(9):1621-9. PubMed ID: 22385013 [TBL] [Abstract][Full Text] [Related]
14. Commentary on Nosyk et al. (2012): detoxification from methadone maintenance therapy: how important is the exact technique that is used? Day E Addiction; 2012 Sep; 107(9):1630-1. PubMed ID: 22861675 [No Abstract] [Full Text] [Related]